← Search

Omics · study · 2026

Microsatellite-stable colorectal tumor-derived SEMA3A drives CD8⁺ T cell senescence and immunotherapy resistance via TCF1 repression

Listed in NCBI GEO

Microsatellite-stable (MSS) colorectal cancers (CRC) display inherent insensitivity to immune checkpoint blockade, and the pivotal mechanisms responsible for this immunotherapeutic resistance have not been fully clarified.

Description

Here, we demonstrate that MSS CRC elicit CD8⁺ T cell senescence to mediate immune evasion, which distinguishes them from microsatellite-instable (MSI) CRC. We further identify SEMA3A, a secreted protein markedly upregulated in MSS CRC, as a crucial mediator that directly drives CD8⁺ T cell senescence.

Mechanistically, SEMA3A engages neuropilin-1 (NRP1) to hijack JAK1 signaling, which blunts cytokine-triggered STAT3 phosphorylation and ultimately reduces TCF1 expression. At the molecular level, TCF1 directly binds to and transcriptionally represses senescence-associated genes. The loss of TCF1 in CD8⁺ T cells infiltrating MSS CRC tumors abolishes this transcriptional repression, thereby inducing CD8⁺ T cell senescence and conferring refractoriness to PD-L1 blockade.

Read the rest (1 more)

In syngeneic murine models of MSS CRC, dual neutralization of SEMA3A and PD-L1 restores TCF1 expression, rescues CD8⁺ T cells from senescence, and significantly improves immunotherapy efficacy. Clinical data corroborate that SEMA3A expression is positively correlated with CD8⁺ T cell senescence and serves as a reliable prognostic biomarker for inferior immunotherapy responses in patients with MSS CRC. Collectively, this study delineates a SEMA3A/NRP1-JAK1-STAT3-TCF1 signaling axis that governs CD8⁺ T cell senescence and tumor immune evasion in MSS CRCs, validating SEMA3A as a promising predictive biomarker and druggable therapeutic target for this immunotherapy-refractory MSS CRC.

Links

Where it is published

Documentation and papers

Topics

From keywords
Life Sciences
Inferred from text
Cancer 65%

Related

Provenance · 1 source records, 8 field assertions
SourceKeyLast seenRaw
NCBI GEOGSE34392814 d agoJSON v1
FieldAssertionExtractorEvidence
access_levelsource · NCBI GEOconnector:ncbi_geo@1.0.0
concepts[disease].local:disease:cancerenrichment · NCBI GEOkeyword-concept-rules@1.0.0title+description (65%)
concepts[field].local:field:life-sciencesmapping · NCBI GEOconnector:ncbi_geo@1.0.0
concepts[method].geo_series_type:genome-binding-occupancy-profiling-by-high-throughput-sequencingsource · NCBI GEOconnector:ncbi_geo@1.0.0/gdstype
concepts[organism].NCBITaxon:10090source · NCBI GEOconnector:ncbi_geo@1.0.0/taxon
descriptionsource · NCBI GEOconnector:ncbi_geo@1.0.0/summary
publication_datesource · NCBI GEOconnector:ncbi_geo@1.0.0
titlesource · NCBI GEOconnector:ncbi_geo@1.0.0/title